{"id":20418,"date":"2021-11-09T13:00:11","date_gmt":"2021-11-09T13:00:11","guid":{"rendered":"https:\/\/cannabishealthnews.co.uk\/?p=20418"},"modified":"2021-11-09T11:42:40","modified_gmt":"2021-11-09T11:42:40","slug":"two-years-on-project-twenty21-helps-almost-2000-patients-access-medical-cannabis","status":"publish","type":"post","link":"https:\/\/cannabishealthnews.co.uk\/2021\/11\/09\/two-years-on-project-twenty21-helps-almost-2000-patients-access-medical-cannabis\/","title":{"rendered":"Two years on Project Twenty21 helps almost 2,000 patients access medical cannabis"},"content":{"rendered":"

Project Twenty21 has helped almost 2,000 patients access medical cannabis treatment. Two years on from its launch, the project\u2019s development lead, David Horn, reflects on its progress so far.<\/h3>\n

Project Twenty21 (T21)<\/a> was in conception long before the expression Covid-19 was even coined. Launched by Drug Science, the UK\u2019s charity for drug reform, its initial aim was to enrol 20,000 medical cannabis patients by the end of 2021, in a bid to build Europe\u2019s largest real-world evidence base for the safety and efficacy of medical cannabis.<\/p>\n

But when the groundbreaking project became officially operational in August 2020 the world was well into the depths of the pandemic. The data collection, which had been anticipated to take place through face-to-face consultations and follow-up interviews between patients and their doctors – inside bricks and mortar clinics – was suddenly forced entirely online.<\/p>\n

\n

It’s officially 2 years since the launch of our real-world evidence medical cannabis study, #ProjectTwenty21<\/a>. It’s been a challenging couple of years, but we’re proud to be approaching 2000 patients, and have just added a 5th clinic to our Directory ???? https:\/\/t.co\/a5HG9cC8Ji<\/a> pic.twitter.com\/NXAG0zXwAQ<\/a><\/p>\n

\u2014 Drug Science (ISCD) (@Drug_Science) November 8, 2021<\/a><\/p><\/blockquote>\n